Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
2097.00Today’s High
2159.0052W low
1720.0052W High
2356.40Open Price
2125.40Prev. Close
1884.2500Volume
67532.00Value
143616927.80Fundamentals
Market Cap Cr
17019.10
Price to Earnings
54.90
Price to Book Value
8.10
Dividend Yield
0.00
PE to Growth
-7.10
Op Revenue TTM Cr
2498.14
Net Profit TTM Cr
310.15
Cash From Operating Activity Cr
521.08
Return on Equity %
16.96
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
49.2
Week
55.4
Month
56.5
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
2127.55
PIVOT
First Resistance
2158.10
Second Resistance
2189.55
Third Resistance
2220.10
First Support
2096.10
Second Support
2065.55
Third Support
2034.10
Relative Strength Index
63.34
Money Flow Index
76.89
MACD
50.35
MACD Signal
43.74
Average True Range
63.45
Average Directional Index
31.74
Rate of Change (21)
15.14
Rate of Change (125)
9.41
Commodity Channel Index
77.3
Williams %R
-34.5
BETA
1 Month
0.16
3 Month
0.18
1 Year
0.25
3 Year
0.25
PRICE CHANGE ANALYSIS
↓ -0.08%
1 Week
Low
High
2075
2186.8
↑ 16.03%
1 Month
Low
High
1750
2189.95
↑ 3.76%
3 Months
Low
High
1750
2189.95
↑ 9.34%
6 Months
Low
High
1750
2356.4
↑ 21.09%
1 Year
Low
High
1720
2356.4
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 308.74 | 306.29 | 319.81 | 302.74 | 298.32 | 290.70 | 299.84 | 266.66 | 262.21 | 276.30 | 293.51 | |
| Operating Expenses Qtr | 218.56 | 214.58 | 217.95 | 206.56 | 189.03 | 193.54 | 204.35 | 184.82 | 166.22 | 174.43 | 186.09 | |
| Operating Profit Qtr | 86.29 | 87.48 | 98.29 | 92.34 | 104.33 | 89.97 | 87.86 | 78.13 | 88.27 | 98.77 | 98.09 | |
| EBIDT Qtr Cr | 90.19 | 91.71 | 101.86 | 96.18 | 109.30 | 97.16 | 95.49 | 81.84 | 95.99 | 101.87 | 107.42 | |
| Depreciation Qtr | 20.41 | 12.78 | 12.79 | 12.12 | 11.16 | 11.35 | 11.38 | 11.41 | 11.35 | 11.41 | 11.42 | |
| Net Profit Qtr | 48.19 | 58.35 | 66.16 | 62.63 | 74.70 | 64.47 | 61.20 | 52.12 | 63.91 | 66.99 | 71.31 | |
| Basic EPS Qtr | 6.02 | 7.29 | 8.27 | 7.83 | 9.33 | 8.06 | 7.65 | 6.51 | 7.99 | 8.37 | 8.91 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1237.59 | 1155.52 | 1167.55 | 942.30 | 797.06 | |
| Operating Expenses Annual Cr | 857.65 | 771.74 | 747.16 | 628.66 | 587.32 | |
| Operating Profit Annual | 364.41 | 360.28 | 396.22 | 304.03 | 202.65 | |
| Operating Profit Margin Annual % | 29.44 | 31.18 | 33.94 | 32.26 | 25.42 | |
| Total Expenses Annual Cr | 919.41 | 818.19 | 796.55 | 688.04 | 650.55 | |
| EBIDT Annual Cr | 379.94 | 383.78 | 420.39 | 313.64 | 209.74 | |
| EBIDT Annual margin % | 30.70 | 33.21 | 36.01 | 33.28 | 26.31 | |
| Depreciation | 58.11 | 45.30 | 44.92 | 44.60 | 42.66 | |
| PAT Before ExtraOrdinary Items Annual Cr | 235.34 | 252.49 | 278.37 | 188.65 | 121.11 | |
| Net Profit Annual | 235.34 | 252.49 | 278.37 | 188.65 | 121.11 | |
| Basic EPS Annual | 29.41 | 31.55 | 35.04 | 25.20 | 16.26 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1866.45 | 1630.86 | 1377.55 | 907.32 | 623.82 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 320.79 | 61.53 | 56.98 | 116.31 | 195.36 | |
| Total Current Liabilities Annual Cr | 209.26 | 119.68 | 134.25 | 190.09 | 137.95 | |
| Total Capital Plus Liabilities Annual Cr | 2396.51 | 1812.07 | 1568.78 | 1213.73 | 957.44 | |
| Fixed Assets Annual | 965.90 | 628.25 | 605.16 | 589.99 | 561.45 | |
| Total Non Current Assets Annual | 2091.68 | 1575.02 | 1237.50 | 846.50 | 788.21 | |
| Total Current Assets Annual | 304.82 | 237.04 | 331.28 | 367.23 | 169.24 | |
| Total Assets Annual | 2396.51 | 1812.07 | 1568.78 | 1213.73 | 957.44 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 762.85 | 176.56 | 164.25 | 1.12 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 262.39 | 269.96 | 284.37 | 291.35 | 160.59 | |
| Cash from Investing Activity Annual | -568.65 | -236.58 | -375.08 | -316.60 | -108.03 | |
| Cash from Financing Annual Activity | 288.64 | -15.14 | 75.98 | 25.37 | -24.35 | |
| Net Cash Flow Annual | - | 18.24 | -14.73 | 0.12 | 28.21 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 233.22 | 203.79 | 172.13 | 116.93 | 83.75 | |
| ROE Annual % | 12.60 | 15.48 | 20.20 | 20.79 | 19.41 | |
| ROCE Annual % | 14.71 | 20.00 | 26.17 | 26.28 | 20.38 | |
| Total Debt to Total Equity Annual | 0.17 | 0.00 | 0.01 | 0.13 | 0.24 | |
| EBDIT Annual Margin % | 31.09 | 33.90 | 36.76 | 33.62 | 26.54 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 637.60 | 609.09 | 655.36 | 609.14 | 580.81 | 568.61 | 573.28 | 500.85 | 380.53 | 395.96 | 417.15 | |
| Operating Expenses Qtr | 474.83 | 458.71 | 475.21 | 448.96 | 412.69 | 410.98 | 411.64 | 358.35 | 258.76 | 263.81 | 282.96 | |
| Operating Profit Qtr | 158.97 | 147.12 | 177.27 | 157.06 | 163.23 | 151.18 | 152.43 | 137.16 | 113.58 | 129.76 | 128.78 | |
| EBIDT Qtr Cr | 162.78 | 150.38 | 180.13 | 160.18 | 168.12 | 157.63 | 176.47 | 142.50 | 121.77 | 132.15 | 134.19 | |
| Depreciation Qtr | 46.30 | 35.38 | 32.61 | 32.27 | 35.43 | 33.29 | 31.12 | 29.42 | 18.64 | 18.81 | 18.14 | |
| Net Profit Qtr | 65.47 | 71.84 | 92.02 | 80.81 | 93.27 | 75.98 | 97.11 | 69.96 | 80.69 | 81.17 | 81.72 | |
| Basic EPS Qtr | 8.18 | 8.98 | 11.50 | 10.10 | 11.65 | 9.49 | 12.14 | 8.74 | 10.08 | 10.14 | 10.34 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 2511.20 | 2223.55 | 1671.09 | 1340.10 | 1128.73 | |
| Operating Expenses Annual Cr | 1857.72 | 1593.67 | 1135.04 | 959.05 | 877.65 | |
| Operating Profit Annual | 640.43 | 604.01 | 515.79 | 370.88 | 245.00 | |
| Operating Profit Margin Annual % | 25.50 | 27.16 | 30.87 | 27.68 | 21.71 | |
| Total Expenses Annual Cr | 2051.29 | 1753.47 | 1223.74 | 1061.09 | 988.20 | |
| EBIDT Annual Cr | 653.48 | 629.88 | 536.05 | 381.05 | 251.08 | |
| EBIDT Annual margin % | 26.02 | 28.33 | 32.08 | 28.43 | 22.24 | |
| Depreciation | 146.55 | 129.26 | 72.67 | 69.54 | 70.61 | |
| PAT Before ExtraOrdinary Items Annual Cr | 336.26 | 365.81 | 334.29 | 205.48 | 115.07 | |
| Net Profit Annual | 310.15 | 336.32 | 332.69 | 201.22 | 119.18 | |
| Basic EPS Annual | 38.75 | 42.03 | 41.88 | 26.42 | 15.87 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1828.36 | 1669.54 | 1387.31 | 863.73 | 598.12 | |
| Minority Interest Liability Annual Cr | 264.88 | 268.42 | 23.33 | 12.46 | 13.30 | |
| Total Non Current Liabilities Annual Cr | 1306.49 | 706.87 | 281.70 | 281.63 | 365.65 | |
| Total Current Liabilities Annual Cr | 452.29 | 296.47 | 215.00 | 278.32 | 218.81 | |
| Total Capital Plus Liabilities Annual Cr | 3852.02 | 2941.30 | 1907.35 | 1436.15 | 1195.89 | |
| Fixed Assets Annual | 2725.99 | 1935.25 | 941.19 | 855.55 | 833.43 | |
| Total Non Current Assets Annual | 3259.07 | 2463.66 | 1513.95 | 984.96 | 976.06 | |
| Total Current Assets Annual | 592.95 | 477.64 | 393.40 | 451.19 | 219.83 | |
| Total Assets Annual | 3852.02 | 2941.30 | 1907.35 | 1436.15 | 1195.89 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 458.97 | 103.57 | 42.37 | 27.49 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 521.09 | 432.09 | 324.02 | 355.97 | 201.50 | |
| Cash from Investing Activity Annual | -752.56 | -615.60 | -411.52 | -354.18 | -124.71 | |
| Cash from Financing Annual Activity | 216.75 | 88.34 | 61.00 | 9.82 | -44.34 | |
| Net Cash Flow Annual | - | -95.17 | -26.50 | 11.62 | 32.45 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 261.56 | 242.16 | 176.27 | 112.92 | 82.08 | |
| ROE Annual % | 16.96 | 20.14 | 23.98 | 23.29 | 19.92 | |
| ROCE Annual % | 14.91 | 18.92 | 27.38 | 26.90 | 18.47 | |
| Total Debt to Total Equity Annual | 0.74 | 0.32 | 0.12 | 0.33 | 0.55 | |
| EBDIT Annual Margin % | 26.15 | 28.66 | 32.47 | 28.65 | 22.36 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sbi Small Cap Fund | 7.2 | 74546613 | - | - |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund | 4.81 | 74546614 | - | - |
| HDFC Small Cap Fund | 4.25 | 74546615 | - | - |
| Icici Prudential Long Term Equity Fund Tax Savings | 1.68 | 74546616 | - | - |
| Kotak Small Cap Fund | 1.04 | 74546620 | - | - |
| Hdfc Life Insurance Company Limited | 1.77 | 74546622 | - | - |
| Amansa Holdings Private Limited | 2.02 | 74546629 | - | - |
| Nomura India Investment Fund Mother Fund | 1.77 | 74546631 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Bhaskara Rao Bollineni | 26.27 | 74546600 | 5.87 | 53.28 |
| Bollineni Seenaiah Naidu | 4.27 | 74546601 | 100 | 0 |
| Rajyasri Bollineni | 1.72 | 74546602 | 0 | 0 |
| Bollineni Ramanaiah Memorial Hospitals Pvt Ltd | 6.05 | 74546610 | 0 | 100 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Sbi Small Cap Fund | 7.2 | 74546613 |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund | 4.81 | 74546614 |
| HDFC Small Cap Fund | 4.25 | 74546615 |
| Icici Prudential Long Term Equity Fund Tax Savings | 1.68 | 74546616 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 1.33 | 74546617 |
| Hsbc Small Cap Fund | 1.31 | 74546618 |
| Mirae Asset Aggressive Hybrid Fund | 1.17 | 74546619 |
| Kotak Small Cap Fund | 1.04 | 74546620 |
| Amansa Holdings Private Limited | 2.02 | 74546629 |
| Emerald Investments Limited | 1.96 | 74546630 |
| Nomura India Investment Fund Mother Fund | 1.77 | 74546631 |
| Hdfc Life Insurance Company Limited | 1.77 | 74546622 |
| Sbi Life Insurance Co. Ltd | 1.77 | 74546623 |
| Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 | 1.64 | 74546624 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| AICPK9496N | 1.26 | 74546640 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Jun 28, 2024 | Stock Split | - |
| May 16, 2024 | Audited Results | - |
| Feb 03, 2024 | Quarterly Results | - |
| Nov 07, 2023 | Quarterly Results | - |
| Aug 07, 2023 | Quarterly Results | - |
| May 18, 2023 | Audited Results | - |
| Feb 09, 2023 | Quarterly Results | - |
| Jan 04, 2023 | Others | inter alia, to consider and approve raising of funds by way of issuance of Non-Convertible Debentures (NCDs), aggregating to Rs. 300 Crores in one or more tranches over a period of time. |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| May 19, 2022 | Audited Results & Dividend | - |
| Feb 10, 2022 | Quarterly Results | - |
| Nov 10, 2021 | Quarterly Results | - |
| Aug 10, 2021 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
28 Jun 2024
Krishna Institute of Medical Sciences Ltd - 543308 - Intimation Under Regulation 31A Of Sebl (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Amendments Thereof.
Approval of Board of Directors for Re-classification of Promoter Group to Public Category.
28 Jun 2024
Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Board Approved Re-Classification Of Persons Falling Under Promoter Group And Sub-Division/Stock Split Of Equity Shares Of The Company
The Board approved Re-classification of persons falling under Promoter Group and Sub-division/Stock Split of equity shares of the Company
25 Jun 2024
KIMS share price zooms 6% after proposing stock split; details here
Shares of Krishna Institute of Medical Sciences (KIMS) shot up to 6.4 per cent at Rs 2187 per share on the BSE in Tuesday's intraday deals
24 Jun 2024
Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 28.06.2024
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2024 ,inter alia, to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, June 28th, 2024 to consider the following items: a) Sub-division/split of existing 1 (One) Equity Share of the face value of Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) Equity Shares of the face value of Rs. 2/- (Rupees Two Only) each fully paid up. b) Reclassification of the persons from the ''Promoter Group' Category to the ''Public'' Category.
24 Jun 2024
Krishna Institute of Medical Sciences Ltd - 543308 - Closure of Trading Window
Closure of trading window for consideration of unaudited financial results for the 01st quarter ended 30th June 2024.
19 Jun 2024
Krishna Institute of Medical Sciences - Growth To Improve: Prabhudas Lilladher
continue to recommend Buy' with a target price of Rs 2,200/share, valuing at 23 times EV/Ebitda on FY26E.
11 Jun 2024
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Acquisition
The Company has entered into an agreement with Meda Institute of Podiatry Private Limited to acquire 51% stake in it.
09 Jun 2024
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Management of the Company will be meeting various Institutional Investors in Mumbai organized by Prabhudas Lilladher on June 13, 2024.
09 Jun 2024
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Management of the Company will be meeting various Institutional Investors in Mumbai organized by Prabhudas Lilladher on June 12, 2024.
05 Jun 2024
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Management of the Company will be meeting various Institutional Investors in an event named IIFL Hyderabad Caravan organized by IIFL on June 14, 2024.
